{
    "xml": "<topic id=\"PHP3843\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/aciclovir\" basename=\"aciclovir\" title=\"ACICLOVIR\">\n<title>ACICLOVIR</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_392\" namespace=\"/interactions/list-of-drug-interactions/antivirals/aciclovir\">Aciclovir</xref>\n</p>\n<data name=\"vtmid\">41193000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_298642086\" title=\"Nucleoside analogues\">Nucleoside analogues</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n<p outputclass=\"synonyms\">Acyclovir</p>\r\n</body>\n<topic id=\"PHP35244\" outputclass=\"indicationsAndDose\" rev=\"1.54\" parent=\"/drugs/aciclovir\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex infection (local treatment)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the eye using eye ointment</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply 1&#8239;centimetre 5 times a day continue for at least 3 days after complete healing.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 1&#8239;centimetre 5 times a day continue for at least 3 days after complete healing.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply 5 times a day for 5&#8211;10 days, to be applied to lesions every 4 hours, starting at first sign of attack.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 5 times a day for 5&#8211;10 days, to be applied to lesions every 4 hours, starting at first sign of attack.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex, suppression</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>400&#8239;mg twice daily, alternatively 200&#8239;mg 4 times a day; increased to 400&#8239;mg 3 times a day, dose may be increased if recurrences occur on standard suppressive therapy or for suppression of genital herpes during late pregnancy (from 36 weeks gestation), therapy interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;mg twice daily, alternatively 200&#8239;mg 4 times a day; increased to 400&#8239;mg 3 times a day, dose may be increased if recurrences occur on standard suppressive therapy or for suppression of genital herpes during late pregnancy (from 36 weeks gestation), therapy interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex, prophylaxis in the immunocompromised</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>100&#8211;200&#8239;mg 4 times a day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;17 years</p>\n<p>200&#8211;400&#8239;mg 4 times a day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8211;400&#8239;mg 4 times a day.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg/kg every 8&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex, treatment (non-genital)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>100&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;17 years</p>\n<p>200&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes simplex, treatment (non-genital) in simplex encephalitis, immunocompromised patients or if absorption impaired</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>200&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;17 years</p>\n<p>400&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Genital herpes simplex, treatment of first episode</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8239;mg 5 times a day, alternatively 400&#8239;mg 3 times a day both courses usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Genital herpes simplex, treatment of severe, initial infection</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8239;mg/kg every 8&#8239;hours usually for 5 days; increased to 10&#8239;mg/kg every 8&#8239;hours for at least 14 days in encephalitis (at least 21 days if also immunocompromised)&#8212;confirm cerebrospinal fluid negative for herpes simplex virus before stop- ping treatment, to be increased only if resistant organisms suspected or in simplex encephalitis.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Genital herpes simplex, treatment of first episode in immunocompromised or HIV-positive patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;mg 5 times a day for 7&#8211;10 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Genital herpes simplex, treatment of recurrent infection</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>800&#8239;mg 3 times a day for 2 days, alternatively 200&#8239;mg 5 times a day for 5 days, alternatively 400&#8239;mg 3 times a day for 3&#8211;5 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Genital herpes simplex, treatment of recurrent infection in immunocompromised or HIV-positive patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;mg 3 times a day for 5&#8211;10 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Varicella zoster (chickenpox), treatment</p>\n<p outputclass=\"therapeuticIndication\">Herpes zoster, treatment</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>200&#8239;mg 4 times a day for 5 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;5 years</p>\n<p>400&#8239;mg 4 times a day for 5 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 years</p>\n<p>800&#8239;mg 4 times a day for 5 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>800&#8239;mg 5 times a day for 7 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>800&#8239;mg 5 times a day for 7 days.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg/kg every 8&#8239;hours usually for 5 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Herpes zoster, treatment in immunocompromised</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>200&#8239;mg 4 times a day continue for 2 days after crusting of lesions.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;5 years</p>\n<p>400&#8239;mg 4 times a day continue for 2 days after crusting of lesions.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;12 years</p>\n<p>800&#8239;mg 4 times a day continue for 2 days after crusting of lesions.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>800&#8239;mg 5 times a day continue for 2 days after crusting of lesions.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>800&#8239;mg 5 times a day continue for 2 days after crusting of lesions.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8239;mg/kg every 8&#8239;hours given for 10&#8211;14 days in encephalitis, possibly longer if also immunocompromised.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Varicella zoster (chickenpox) attenuation of infection if varicella&#8211;zoster immunoglobulin not indicated</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>10&#8239;mg/kg 4 times a day for 7 days, to be started 1 week after exposure.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8239;mg/kg 4 times a day for 7 days, to be started 1 week after exposure.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"extremesOfBodyWeight\">\n<title>Doses at extremes of body-weight</title>\n<p>To avoid excessive dosage in obese patients parenteral dose should be calculated on the basis of ideal weight for height.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34950\" outputclass=\"unlicensedUse\" rev=\"1.37\" parent=\"/drugs/aciclovir\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use in children</p>\n<p>Cream licensed for use in children (age range not specified by manufacturer).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>Tablets and suspension not licensed for attenuation of chickenpox (if varicella-zoster immunoglobulin not indicated) in children under 18 years.</p>\n<p>Tablets and suspension not licensed for suppression of herpes simplex or for treatment of herpes zoster in children (age range not specified by manufacturer).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>Intravenous infusion not licensed for herpes zoster in children under 18 years.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Aciclovir doses in BNF may differ from those in product literature (systemic use).</p>\n<p>Attenuation of chickenpox is an unlicensed indication.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35323\" outputclass=\"cautions\" rev=\"1.16\" parent=\"/drugs/aciclovir\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With systemic use</p>\n<p>\n<ph outputclass=\"caution\">elderly (risk of neurological reactions)</ph> (in adults); <ph outputclass=\"caution\">maintain adequate hydration (especially with infusion or high doses)</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With topical use</p>\n<p>\n<ph outputclass=\"caution\">avoid cream coming in to contact with eyes and mucous membranes</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35237\" outputclass=\"interactions\" rev=\"1.14\" parent=\"/drugs/aciclovir\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>Appendix 1 (aciclovir).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34981\" outputclass=\"sideEffects\" rev=\"1.19\" parent=\"/drugs/aciclovir\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"specificSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by eye</p>\n<p>\n<ph outputclass=\"sideEffect\">local inflammation</ph>; <ph outputclass=\"sideEffect\">local irritation</ph>; <ph outputclass=\"sideEffect\">superficial punctate keratopathy</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With systemic use</p>\n<p>\n<ph outputclass=\"sideEffect\">abdominal pain</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by eye</p>\n<p>\n<ph outputclass=\"sideEffect\">blepharitis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by eye</p>\n<p>\n<ph outputclass=\"sideEffect\">angioedema</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">agitation</ph>; <ph outputclass=\"sideEffect\">fever</ph>; <ph outputclass=\"sideEffect\">psychosis</ph>; <ph outputclass=\"sideEffect\">severe local inflammation (sometimes leading to ulceration)</ph>; <ph outputclass=\"sideEffect\">tremors</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With systemic use</p>\n<p>\n<ph outputclass=\"sideEffect\">acute renal failure</ph>; <ph outputclass=\"sideEffect\">anaemia</ph>; <ph outputclass=\"sideEffect\">ataxia</ph>; <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">convulsions</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">dysarthria</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">hallucinations</ph>; <ph outputclass=\"sideEffect\">hepatitis</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">neurological reactions</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With topical use</p>\n<p>\n<ph outputclass=\"sideEffect\">drying of the skin</ph>; <ph outputclass=\"sideEffect\">erythema</ph>; <ph outputclass=\"sideEffect\">itching of the skin</ph>; <ph outputclass=\"sideEffect\">transient burning</ph>; <ph outputclass=\"sideEffect\">transient stinging</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35211\" outputclass=\"pregnancy\" parent=\"/drugs/aciclovir\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>Not known to be harmful&#8212;manufacturers advise use only when potential benefit outweighs risk.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use</p>\n<p>Limited absorption from topical aciclovir preparations.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35331\" outputclass=\"breastFeeding\" parent=\"/drugs/aciclovir\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>Significant amount in milk after systemic administration&#8212;not known to be harmful but manufacturer advises caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35195\" outputclass=\"renalImpairment\" parent=\"/drugs/aciclovir\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>Use normal intravenous dose every 12 hours if eGFR 25&#8211;50&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup> (every 24 hours if eGFR 10&#8211;25 mL/minute/ 1.73&#8239;m<sup>2</sup>). </p>\n<p>Consult product literature for intravenous dose if eGFR less than 10&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use in adults</p>\n<p>For <i>herpes zoster</i>, use normal oral dose every 8 hours if eGFR 10&#8211;25&#8239;mL/minute/1.73&#8239;m<sup>2</sup> (every 12 hours if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>).</p>\n<p>For <i>herpes simplex</i>, use normal oral dose every 12 hours if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use in children</p>\n<p>Use <i>normal intravenous dose</i> every 12 hours if estimated glomerular filtration rate 25&#8211;50&#8239;mL/minute/1.73m<sup>2</sup> (every 24 hours if estimated glomerular filtration rate 10&#8211;25&#8239;mL/minute/1.73m<sup>2</sup>.</p>\n<p>Consult product literature for intravenous dose if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73<sup>2</sup>.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use in children</p>\n<p>For <i>herpes zoster</i>, use normal oral dose every 8 hours if estimated glomerular filtration rate 10&#8211;25&#8239;mL/minute/1.73m<sup>2</sup> (every 12 hours if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73m<sup>2</sup>.</p>\n<p>For <i>herpes simplex</i>, use normal dose every 12 hours if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>Risk of neurological reactions increased.</p>\n<p>Maintain adequate hydration (especially during renal impairment).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35348\" outputclass=\"directionsForAdministration\" rev=\"1.15\" parent=\"/drugs/aciclovir\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>intravenous infusion</i>, reconstitute to 25&#8239;mg/mL with Water for Injections or Sodium Chloride 0.9% then dilute to concentration of 5&#8239;mg/mL with Sodium Chloride 0.9% or Sodium Chloride and Glucose and give over 1 hour; alternatively, may be administered in a concentration of 25&#8239;mg/mL using a suitable infusion pump and central venous access and given over 1 hour.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i>\n<i>Zovirax IV</i>\n<tm tmtype=\"reg\"/>, <i>Aciclovir IV</i>(Genus), give intermittently <i>in</i> Sodium chloride 0.9% <i>or</i> Sodium chloride and glucose; initially reconstitute to 25&#8239;mg/mL in water for injection or sodium chloride 0.9% then dilute to not more than 5&#8239;mg/mL with the infusion fluid; to be given over 1 hour; alternatively, may be administered in a concentration of 25&#8239;mg/mL using a suitable infusion pump and given over 1 hour; for <i>Aciclovir IV </i>(Hospira) dilute to not more than 5&#8239;mg/mL with infusion fluid; give over 1 hour.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58661\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.12\" parent=\"/drugs/aciclovir\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Flavours of oral liquid preparations may include banana, or orange.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35205\" outputclass=\"patientAndCarerAdvice\" rev=\"1.15\" parent=\"/drugs/aciclovir\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Aciclovir (oral) for viral infections</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/aciclovir-for-viral-infections\">www.medicinesforchildren.org.uk/aciclovir-for-viral-infections</xref>\n</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Aciclovir cream for herpes</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/aciclovir-cream-for-herpes\">www.medicinesforchildren.org.uk/aciclovir-cream-for-herpes</xref>\n</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Aciclovir eye ointment for herpes simplex infections</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/aciclovir-eye-ointment-for-herpes-simplex-infection\">www.medicinesforchildren.org.uk/aciclovir-eye-ointment-for-herpes-simplex-infection</xref>\n</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP34897\" outputclass=\"professionSpecificInformation\" rev=\"1.9\" parent=\"/drugs/aciclovir\">\n<title>Profession specific information</title>\n<body>\n<section outputclass=\"dentalPractitionersFormulary\">\n<title>Dental practitioners' formulary</title>\n<sectiondiv>\n<p>Aciclovir Tablets 200&#8239;mg or 800&#8239;mg may be prescribed.</p>\n<p>Aciclovir Oral Suspension 200&#8239;mg/5mL may be prescribed.</p>\n<p>Aciclovir Cream may be prescribed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34887\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.11\" parent=\"/drugs/aciclovir\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use</p>\n<p>A 2-g tube and a pump pack are on sale to the public for the treatment of cold sores.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3843-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/aciclovir\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76798\" title=\"Tablet\" namespace=\"/drugs/aciclovir/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76811\" title=\"Dispersible tablet\" namespace=\"/drugs/aciclovir/dispersible-tablet\">Dispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76820\" title=\"Oral suspension\" namespace=\"/drugs/aciclovir/oral-suspension\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76830\" title=\"Solution for infusion\" namespace=\"/drugs/aciclovir/solution-for-infusion\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76824\" title=\"Powder for solution for infusion\" namespace=\"/drugs/aciclovir/powder-for-solution-for-infusion\">Powder for solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76792\" title=\"Eye ointment\" namespace=\"/drugs/aciclovir/eye-ointment\">Eye ointment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76805\" title=\"Cream\" namespace=\"/drugs/aciclovir/cream\">Cream</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78257\" namespace=\"/treatment-summaries/herpesvirus-infections\" title=\"Herpesvirus infections\" count=\"8\" rel=\"backlink\">Herpesvirus infections</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78284\" namespace=\"/treatment-summaries/skin-infections\" title=\"Skin infections\" count=\"3\" rel=\"backlink\">Skin infections</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78412\" namespace=\"/treatment-summaries/vaginal-and-vulval-conditions\" title=\"Vaginal and vulval conditions\" count=\"1\" rel=\"backlink\">Vaginal and vulval conditions</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78418\" namespace=\"/treatment-summaries/oropharynx-infections-viral\" title=\"Oropharynx infections, viral\" count=\"2\" rel=\"backlink\">Oropharynx infections, viral</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78541\" namespace=\"/treatment-summaries/eye-infections-of\" title=\"Eye, infections of\" count=\"2\" rel=\"backlink\">Eye, infections of</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_392\" namespace=\"/interactions/list-of-drug-interactions/antivirals/aciclovir\" title=\"Aciclovir\" count=\"1\" rel=\"link\">Aciclovir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76798\" namespace=\"/drugs/aciclovir/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76811\" namespace=\"/drugs/aciclovir/dispersible-tablet\" title=\"Dispersible tablet\" count=\"1\" rel=\"link\">Dispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76820\" namespace=\"/drugs/aciclovir/oral-suspension\" title=\"Oral suspension\" count=\"1\" rel=\"link\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76830\" namespace=\"/drugs/aciclovir/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76824\" namespace=\"/drugs/aciclovir/powder-for-solution-for-infusion\" title=\"Powder for solution for infusion\" count=\"1\" rel=\"link\">Powder for solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76792\" namespace=\"/drugs/aciclovir/eye-ointment\" title=\"Eye ointment\" count=\"1\" rel=\"link\">Eye ointment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76805\" namespace=\"/drugs/aciclovir/cream\" title=\"Cream\" count=\"1\" rel=\"link\">Cream</xref>\n</links>\n</topic>",
    "id": "PHP3843",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/aciclovir",
    "basename": "aciclovir",
    "title": "ACICLOVIR",
    "interactants": [
        {
            "id": "bnf_int_392",
            "label": "Aciclovir"
        }
    ],
    "vtmid": "41193000",
    "drugClassification": [
        "Nucleoside analogues"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Acyclovir"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex infection (local treatment)",
                        "html": "Herpes simplex infection (local treatment)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "child": [
                    {
                        "textContent": "Apply 1 centimetre 5 times a day continue for at least 3 days after complete healing.",
                        "html": "<p>Apply 1&#8239;centimetre 5 times a day continue for at least 3 days after complete healing.</p>"
                    },
                    {
                        "textContent": "Apply 5 times a day for 5&#8211;10 days, to be applied to lesions every 4 hours, starting at first sign of attack.",
                        "html": "<p>Apply 5 times a day for 5&#8211;10 days, to be applied to lesions every 4 hours, starting at first sign of attack.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply 1 centimetre 5 times a day continue for at least 3 days after complete healing.",
                        "html": "<p>Apply 1&#8239;centimetre 5 times a day continue for at least 3 days after complete healing.</p>"
                    },
                    {
                        "textContent": "Apply 5 times a day for 5&#8211;10 days, to be applied to lesions every 4 hours, starting at first sign of attack.",
                        "html": "<p>Apply 5 times a day for 5&#8211;10 days, to be applied to lesions every 4 hours, starting at first sign of attack.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex, suppression",
                        "html": "Herpes simplex, suppression"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "400 mg twice daily, alternatively 200 mg 4 times a day; increased to 400 mg 3 times a day, dose may be increased if recurrences occur on standard suppressive therapy or for suppression of genital herpes during late pregnancy (from 36 weeks gestation), therapy interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.",
                        "html": "<p>400&#8239;mg twice daily, alternatively 200&#8239;mg 4 times a day; increased to 400&#8239;mg 3 times a day, dose may be increased if recurrences occur on standard suppressive therapy or for suppression of genital herpes during late pregnancy (from 36 weeks gestation), therapy interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "400 mg twice daily, alternatively 200 mg 4 times a day; increased to 400 mg 3 times a day, dose may be increased if recurrences occur on standard suppressive therapy or for suppression of genital herpes during late pregnancy (from 36 weeks gestation), therapy interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.",
                        "html": "<p>400&#8239;mg twice daily, alternatively 200&#8239;mg 4 times a day; increased to 400&#8239;mg 3 times a day, dose may be increased if recurrences occur on standard suppressive therapy or for suppression of genital herpes during late pregnancy (from 36 weeks gestation), therapy interrupted every 6&#8211;12 months to reassess recurrence frequency&#8212;consider restarting after two or more recurrences.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex, prophylaxis in the immunocompromised",
                        "html": "Herpes simplex, prophylaxis in the immunocompromised"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "100&#8211;200 mg 4 times a day.",
                        "html": "<p>100&#8211;200&#8239;mg 4 times a day.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "200&#8211;400 mg 4 times a day.",
                        "html": "<p>200&#8211;400&#8239;mg 4 times a day.</p>",
                        "ageGroup": "2&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "200&#8211;400 mg 4 times a day.",
                        "html": "<p>200&#8211;400&#8239;mg 4 times a day.</p>"
                    },
                    {
                        "textContent": "5 mg/kg every 8 hours.",
                        "html": "<p>5&#8239;mg/kg every 8&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex, treatment (non-genital)",
                        "html": "Herpes simplex, treatment (non-genital)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "100 mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).",
                        "html": "<p>100&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "200 mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).",
                        "html": "<p>200&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>",
                        "ageGroup": "2&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "200 mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).",
                        "html": "<p>200&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes simplex, treatment (non-genital) in simplex encephalitis, immunocompromised patients or if absorption impaired",
                        "html": "Herpes simplex, treatment (non-genital) in simplex encephalitis, immunocompromised patients or if absorption impaired"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "200 mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).",
                        "html": "<p>200&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "400 mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).",
                        "html": "<p>400&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>",
                        "ageGroup": "2&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "400 mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).",
                        "html": "<p>400&#8239;mg 5 times a day usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Genital herpes simplex, treatment of first episode",
                        "html": "Genital herpes simplex, treatment of first episode"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "200 mg 5 times a day, alternatively 400 mg 3 times a day both courses usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).",
                        "html": "<p>200&#8239;mg 5 times a day, alternatively 400&#8239;mg 3 times a day both courses usually for 5 days (longer if new lesions appear during treatment or if healing incomplete).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Genital herpes simplex, treatment of severe, initial infection",
                        "html": "Genital herpes simplex, treatment of severe, initial infection"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 5 mg/kg every 8 hours usually for 5 days; increased to 10 mg/kg every 8 hours for at least 14 days in encephalitis (at least 21 days if also immunocompromised)&#8212;confirm cerebrospinal fluid negative for herpes simplex virus before stop- ping treatment, to be increased only if resistant organisms suspected or in simplex encephalitis.",
                        "html": "<p>Initially 5&#8239;mg/kg every 8&#8239;hours usually for 5 days; increased to 10&#8239;mg/kg every 8&#8239;hours for at least 14 days in encephalitis (at least 21 days if also immunocompromised)&#8212;confirm cerebrospinal fluid negative for herpes simplex virus before stop- ping treatment, to be increased only if resistant organisms suspected or in simplex encephalitis.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Genital herpes simplex, treatment of first episode in immunocompromised or HIV-positive patients",
                        "html": "Genital herpes simplex, treatment of first episode in immunocompromised or HIV-positive patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "400 mg 5 times a day for 7&#8211;10 days.",
                        "html": "<p>400&#8239;mg 5 times a day for 7&#8211;10 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Genital herpes simplex, treatment of recurrent infection",
                        "html": "Genital herpes simplex, treatment of recurrent infection"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "800 mg 3 times a day for 2 days, alternatively 200 mg 5 times a day for 5 days, alternatively 400 mg 3 times a day for 3&#8211;5 days.",
                        "html": "<p>800&#8239;mg 3 times a day for 2 days, alternatively 200&#8239;mg 5 times a day for 5 days, alternatively 400&#8239;mg 3 times a day for 3&#8211;5 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Genital herpes simplex, treatment of recurrent infection in immunocompromised or HIV-positive patients",
                        "html": "Genital herpes simplex, treatment of recurrent infection in immunocompromised or HIV-positive patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "400 mg 3 times a day for 5&#8211;10 days.",
                        "html": "<p>400&#8239;mg 3 times a day for 5&#8211;10 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Varicella zoster (chickenpox), treatment",
                        "html": "Varicella zoster (chickenpox), treatment"
                    },
                    {
                        "textContent": "Herpes zoster, treatment",
                        "html": "Herpes zoster, treatment"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "200 mg 4 times a day for 5 days.",
                        "html": "<p>200&#8239;mg 4 times a day for 5 days.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "400 mg 4 times a day for 5 days.",
                        "html": "<p>400&#8239;mg 4 times a day for 5 days.</p>",
                        "ageGroup": "2&#8211;5 years"
                    },
                    {
                        "textContent": "800 mg 4 times a day for 5 days.",
                        "html": "<p>800&#8239;mg 4 times a day for 5 days.</p>",
                        "ageGroup": "6&#8211;11 years"
                    },
                    {
                        "textContent": "800 mg 5 times a day for 7 days.",
                        "html": "<p>800&#8239;mg 5 times a day for 7 days.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "800 mg 5 times a day for 7 days.",
                        "html": "<p>800&#8239;mg 5 times a day for 7 days.</p>"
                    },
                    {
                        "textContent": "5 mg/kg every 8 hours usually for 5 days.",
                        "html": "<p>5&#8239;mg/kg every 8&#8239;hours usually for 5 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Herpes zoster, treatment in immunocompromised",
                        "html": "Herpes zoster, treatment in immunocompromised"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "200 mg 4 times a day continue for 2 days after crusting of lesions.",
                        "html": "<p>200&#8239;mg 4 times a day continue for 2 days after crusting of lesions.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "400 mg 4 times a day continue for 2 days after crusting of lesions.",
                        "html": "<p>400&#8239;mg 4 times a day continue for 2 days after crusting of lesions.</p>",
                        "ageGroup": "2&#8211;5 years"
                    },
                    {
                        "textContent": "800 mg 4 times a day continue for 2 days after crusting of lesions.",
                        "html": "<p>800&#8239;mg 4 times a day continue for 2 days after crusting of lesions.</p>",
                        "ageGroup": "6&#8211;12 years"
                    },
                    {
                        "textContent": "800 mg 5 times a day continue for 2 days after crusting of lesions.",
                        "html": "<p>800&#8239;mg 5 times a day continue for 2 days after crusting of lesions.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "800 mg 5 times a day continue for 2 days after crusting of lesions.",
                        "html": "<p>800&#8239;mg 5 times a day continue for 2 days after crusting of lesions.</p>"
                    },
                    {
                        "textContent": "10 mg/kg every 8 hours given for 10&#8211;14 days in encephalitis, possibly longer if also immunocompromised.",
                        "html": "<p>10&#8239;mg/kg every 8&#8239;hours given for 10&#8211;14 days in encephalitis, possibly longer if also immunocompromised.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Varicella zoster (chickenpox) attenuation of infection if varicella&#8211;zoster immunoglobulin not indicated",
                        "html": "Varicella zoster (chickenpox) attenuation of infection if varicella&#8211;zoster immunoglobulin not indicated"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "10 mg/kg 4 times a day for 7 days, to be started 1 week after exposure.",
                        "html": "<p>10&#8239;mg/kg 4 times a day for 7 days, to be started 1 week after exposure.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "10 mg/kg 4 times a day for 7 days, to be started 1 week after exposure.",
                        "html": "<p>10&#8239;mg/kg 4 times a day for 7 days, to be started 1 week after exposure.</p>"
                    }
                ]
            }
        ],
        "extremesOfBodyWeight": [
            {
                "type": "extremesOfBodyWeight",
                "title": "Doses at extremes of body-weight",
                "textContent": "To avoid excessive dosage in obese patients parenteral dose should be calculated on the basis of ideal weight for height.",
                "html": "<p>To avoid excessive dosage in obese patients parenteral dose should be calculated on the basis of ideal weight for height.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With topical use in children",
                    "html": "With <ph outputclass=\"route\">topical</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "topical"
                    ]
                },
                "textContent": "Cream licensed for use in children (age range not specified by manufacturer).",
                "html": "<p>Cream licensed for use in children (age range not specified by manufacturer).</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Tablets and suspension not licensed for attenuation of chickenpox (if varicella-zoster immunoglobulin not indicated) in children under 18 years.\n\nTablets and suspension not licensed for suppression of herpes simplex or for treatment of herpes zoster in children (age range not specified by manufacturer).",
                "html": "<p>Tablets and suspension not licensed for attenuation of chickenpox (if varicella-zoster immunoglobulin not indicated) in children under 18 years.</p><p>Tablets and suspension not licensed for suppression of herpes simplex or for treatment of herpes zoster in children (age range not specified by manufacturer).</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Intravenous infusion not licensed for herpes zoster in children under 18 years.",
                "html": "<p>Intravenous infusion not licensed for herpes zoster in children under 18 years.</p>"
            },
            {
                "type": "unlicensedUse",
                "textContent": "Aciclovir doses in BNF may differ from those in product literature (systemic use).\n\nAttenuation of chickenpox is an unlicensed indication.",
                "html": "<p>Aciclovir doses in BNF may differ from those in product literature (systemic use).</p><p>Attenuation of chickenpox is an unlicensed indication.</p>"
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "elderly (risk of neurological reactions) in adults",
                "html": "elderly (risk of neurological reactions) in adults",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With systemic use",
                    "routes": [
                        "systemic"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "maintain adequate hydration (especially with infusion or high doses)",
                "html": "maintain adequate hydration (especially with infusion or high doses)",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With systemic use",
                    "routes": [
                        "systemic"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid cream coming in to contact with eyes and mucous membranes",
                "html": "avoid cream coming in to contact with eyes and mucous membranes",
                "specificity": {
                    "textContent": "With topical use",
                    "html": "With topical use",
                    "routes": [
                        "topical"
                    ]
                }
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Appendix 1 (aciclovir).",
                "html": "<p>Appendix 1 (aciclovir).</p>"
            }
        ]
    },
    "sideEffects": {
        "specific": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "local inflammation",
                        "html": "local inflammation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "local irritation",
                        "html": "local irritation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "superficial punctate keratopathy",
                        "html": "superficial punctate keratopathy",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "abdominal pain",
                        "html": "abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "fatigue",
                        "html": "fatigue",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "blepharitis",
                        "html": "blepharitis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "angioedema",
                        "html": "angioedema",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "agitation",
                        "html": "agitation",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "fever",
                        "html": "fever",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "psychosis",
                        "html": "psychosis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "severe local inflammation (sometimes leading to ulceration)",
                        "html": "severe local inflammation (sometimes leading to ulceration)",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "tremors",
                        "html": "tremors",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "acute renal failure",
                        "html": "acute renal failure",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "anaemia",
                        "html": "anaemia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "ataxia",
                        "html": "ataxia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "convulsions",
                        "html": "convulsions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "dysarthria",
                        "html": "dysarthria",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hallucinations",
                        "html": "hallucinations",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hepatitis",
                        "html": "hepatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "neurological reactions",
                        "html": "neurological reactions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With systemic use",
                            "html": "With systemic use",
                            "routes": [
                                "systemic"
                            ]
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "drying of the skin",
                        "html": "drying of the skin",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With topical use",
                            "html": "With topical use",
                            "routes": [
                                "topical"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "erythema",
                        "html": "erythema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With topical use",
                            "html": "With topical use",
                            "routes": [
                                "topical"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "itching of the skin",
                        "html": "itching of the skin",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With topical use",
                            "html": "With topical use",
                            "routes": [
                                "topical"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "transient burning",
                        "html": "transient burning",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With topical use",
                            "html": "With topical use",
                            "routes": [
                                "topical"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "transient stinging",
                        "html": "transient stinging",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With topical use",
                            "html": "With topical use",
                            "routes": [
                                "topical"
                            ]
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Not known to be harmful&#8212;manufacturers advise use only when potential benefit outweighs risk.",
                "html": "<p>Not known to be harmful&#8212;manufacturers advise use only when potential benefit outweighs risk.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With topical use",
                    "html": "With <ph outputclass=\"route\">topical</ph> use",
                    "routes": [
                        "topical"
                    ]
                },
                "textContent": "Limited absorption from topical aciclovir preparations.",
                "html": "<p>Limited absorption from topical aciclovir preparations.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Significant amount in milk after systemic administration&#8212;not known to be harmful but manufacturer advises caution.",
                "html": "<p>Significant amount in milk after systemic administration&#8212;not known to be harmful but manufacturer advises caution.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Use normal intravenous dose every 12 hours if eGFR 25&#8211;50 mL/minute/ 1.73 m2 (every 24 hours if eGFR 10&#8211;25 mL/minute/ 1.73 m2).\n\nConsult product literature for intravenous dose if eGFR less than 10 mL/minute/ 1.73 m2.",
                "html": "<p>Use normal intravenous dose every 12 hours if eGFR 25&#8211;50&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup> (every 24 hours if eGFR 10&#8211;25 mL/minute/ 1.73&#8239;m<sup>2</sup>). </p><p>Consult product literature for intravenous dose if eGFR less than 10&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With systemic use in adults",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "For herpes zoster, use normal oral dose every 8 hours if eGFR 10&#8211;25 mL/minute/1.73 m2 (every 12 hours if eGFR less than 10 mL/minute/1.73 m2).\n\nFor herpes simplex, use normal oral dose every 12 hours if eGFR less than 10 mL/minute/1.73 m2.",
                "html": "<p>For <i>herpes zoster</i>, use normal oral dose every 8 hours if eGFR 10&#8211;25&#8239;mL/minute/1.73&#8239;m<sup>2</sup> (every 12 hours if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>).</p><p>For <i>herpes simplex</i>, use normal oral dose every 12 hours if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With systemic use in children",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Use normal intravenous dose every 12 hours if estimated glomerular filtration rate 25&#8211;50 mL/minute/1.73m2 (every 24 hours if estimated glomerular filtration rate 10&#8211;25 mL/minute/1.73m2.\n\nConsult product literature for intravenous dose if estimated glomerular filtration rate less than 10 mL/minute/1.732.",
                "html": "<p>Use <i>normal intravenous dose</i> every 12 hours if estimated glomerular filtration rate 25&#8211;50&#8239;mL/minute/1.73m<sup>2</sup> (every 24 hours if estimated glomerular filtration rate 10&#8211;25&#8239;mL/minute/1.73m<sup>2</sup>.</p><p>Consult product literature for intravenous dose if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73<sup>2</sup>.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With systemic use in children",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "For herpes zoster, use normal oral dose every 8 hours if estimated glomerular filtration rate 10&#8211;25 mL/minute/1.73m2 (every 12 hours if estimated glomerular filtration rate less than 10 mL/minute/1.73m2.\n\nFor herpes simplex, use normal dose every 12 hours if estimated glomerular filtration rate less than 10 mL/minute/1.732.",
                "html": "<p>For <i>herpes zoster</i>, use normal oral dose every 8 hours if estimated glomerular filtration rate 10&#8211;25&#8239;mL/minute/1.73m<sup>2</sup> (every 12 hours if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73m<sup>2</sup>.</p><p>For <i>herpes simplex</i>, use normal dose every 12 hours if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73<sup>2</sup>.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Risk of neurological reactions increased.\n\nMaintain adequate hydration (especially during renal impairment).",
                "html": "<p>Risk of neurological reactions increased.</p><p>Maintain adequate hydration (especially during renal impairment).</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion, reconstitute to 25 mg/mL with Water for Injections or Sodium Chloride 0.9% then dilute to concentration of 5 mg/mL with Sodium Chloride 0.9% or Sodium Chloride and Glucose and give over 1 hour; alternatively, may be administered in a concentration of 25 mg/mL using a suitable infusion pump and central venous access and given over 1 hour.",
                "html": "<p>For <i>intravenous infusion</i>, reconstitute to 25&#8239;mg/mL with Water for Injections or Sodium Chloride 0.9% then dilute to concentration of 5&#8239;mg/mL with Sodium Chloride 0.9% or Sodium Chloride and Glucose and give over 1 hour; alternatively, may be administered in a concentration of 25&#8239;mg/mL using a suitable infusion pump and central venous access and given over 1 hour.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion Zovirax IV , Aciclovir IV(Genus), give intermittently in Sodium chloride 0.9% or Sodium chloride and glucose; initially reconstitute to 25 mg/mL in water for injection or sodium chloride 0.9% then dilute to not more than 5 mg/mL with the infusion fluid; to be given over 1 hour; alternatively, may be administered in a concentration of 25 mg/mL using a suitable infusion pump and given over 1 hour; for Aciclovir IV (Hospira) dilute to not more than 5 mg/mL with infusion fluid; give over 1 hour.",
                "html": "<p>For <i>intravenous infusion</i>\n<i>Zovirax IV</i>\n<tm tmtype=\"reg\"/>, <i>Aciclovir IV</i>(Genus), give intermittently <i>in</i> Sodium chloride 0.9% <i>or</i> Sodium chloride and glucose; initially reconstitute to 25&#8239;mg/mL in water for injection or sodium chloride 0.9% then dilute to not more than 5&#8239;mg/mL with the infusion fluid; to be given over 1 hour; alternatively, may be administered in a concentration of 25&#8239;mg/mL using a suitable infusion pump and given over 1 hour; for <i>Aciclovir IV </i>(Hospira) dilute to not more than 5&#8239;mg/mL with infusion fluid; give over 1 hour.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Flavours of oral liquid preparations may include banana, or orange.",
                "html": "<p>Flavours of oral liquid preparations may include banana, or orange.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/aciclovir-for-viral-infections",
                        "label": "www.medicinesforchildren.org.uk/aciclovir-for-viral-infections"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Aciclovir (oral) for viral infections",
                "textContent": "www.medicinesforchildren.org.uk/aciclovir-for-viral-infections",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/aciclovir-for-viral-infections\">www.medicinesforchildren.org.uk/aciclovir-for-viral-infections</xref>\n</p>"
            },
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/aciclovir-cream-for-herpes",
                        "label": "www.medicinesforchildren.org.uk/aciclovir-cream-for-herpes"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Aciclovir cream for herpes",
                "textContent": "www.medicinesforchildren.org.uk/aciclovir-cream-for-herpes",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/aciclovir-cream-for-herpes\">www.medicinesforchildren.org.uk/aciclovir-cream-for-herpes</xref>\n</p>"
            },
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/aciclovir-eye-ointment-for-herpes-simplex-infection",
                        "label": "www.medicinesforchildren.org.uk/aciclovir-eye-ointment-for-herpes-simplex-infection"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Aciclovir eye ointment for herpes simplex infections",
                "textContent": "www.medicinesforchildren.org.uk/aciclovir-eye-ointment-for-herpes-simplex-infection",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/aciclovir-eye-ointment-for-herpes-simplex-infection\">www.medicinesforchildren.org.uk/aciclovir-eye-ointment-for-herpes-simplex-infection</xref>\n</p>"
            }
        ]
    },
    "professionSpecificInformation": {
        "dentalPractitionersFormulary": [
            {
                "type": "dentalPractitionersFormulary",
                "textContent": "Aciclovir Tablets 200 mg or 800 mg may be prescribed.\n\nAciclovir Oral Suspension 200 mg/5mL may be prescribed.\n\nAciclovir Cream may be prescribed.",
                "html": "<p>Aciclovir Tablets 200&#8239;mg or 800&#8239;mg may be prescribed.</p><p>Aciclovir Oral Suspension 200&#8239;mg/5mL may be prescribed.</p><p>Aciclovir Cream may be prescribed.</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "specificity": {
                    "textContent": "With topical use",
                    "html": "With <ph outputclass=\"route\">topical</ph> use",
                    "routes": [
                        "topical"
                    ]
                },
                "textContent": "A 2-g tube and a pump pack are on sale to the public for the treatment of cold sores.",
                "html": "<p>A 2-g tube and a pump pack are on sale to the public for the treatment of cold sores.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76798",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76811",
                "label": "Dispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76820",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76830",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76824",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76792",
                "label": "Eye ointment",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76805",
                "label": "Cream",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78257",
                "label": "Herpesvirus infections",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78284",
                "label": "Skin infections",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78412",
                "label": "Vaginal and vulval conditions",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78418",
                "label": "Oropharynx infections, viral",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78541",
                "label": "Eye, infections of",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_392",
                "label": "Aciclovir",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76798",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76811",
                "label": "Dispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76820",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76830",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76824",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76792",
                "label": "Eye ointment",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76805",
                "label": "Cream",
                "type": "medicinalForm"
            }
        ]
    }
}